JJIJ

Johnson & Johnson Innovation - JJDC Portfolio holdings

AUM $978M
1-Year Est. Return 101.76%
This Quarter Est. Return
1 Year Est. Return
+101.76%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$277M
AUM Growth
–
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

1
+$207M
2
+$20.7M
3
+$17.3M
4
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$16.8M
5
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
+$9.82M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 99.44%
2 Technology 0.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$207M 74.59%
+3,260,869
2
$20.7M 7.45%
+213,340
3
$17.3M 6.23%
+2,449,183
4
$16.8M 6.04%
+1,124,973
5
$9.82M 3.54%
+1,607,044
6
$3.46M 1.25%
+594,834
7
$1.08M 0.39%
+811,295
8
$481K 0.17%
+525,632
9
$456K 0.16%
+8,927
10
$298K 0.11%
+143,964
11
$197K 0.07%
+4,200